The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cancer outcomes from a real-world cohort of patients eligible for adjuvant CDK4/6 inhibitors but without genomic risk for chemotherapy: A GBECAM multicenter retrospective study.
 
Leandro Jonata Carvalho Oliveira
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Daniela Dornelles Rosa
Consulting or Advisory Role - Amgen; AstraZeneca; GlaxoSmithKline; Libbs; Lilly; Novartis; Pfizer; Roche; Sanofi; Zodiac Pharma
Speakers' Bureau - Lilly; Novartis; Pfizer
Travel, Accommodations, Expenses - Roche
 
Artur Katz
No Relationships to Disclose
 
Daniele Assad Suzuki
Consulting or Advisory Role - Daiichi Sankyo/Lilly
Travel, Accommodations, Expenses - AstraZeneca
 
Daniel F. Argolo
No Relationships to Disclose
 
Solange Moraes Sanches
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; MSD Oncology
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Lilly
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca
 
Laura Testa
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; Lilly; Lilly; MSD Oncology; MSD Oncology; MSD/AstraZeneca; Novartis; Pfizer
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Lilly; MSD Oncology; Novartis; Pfizer
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Roche
 
Jose Bines
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Knight Pharmaceuticals; Lilly; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; MSD; Pfizer; Roche
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Roche
 
Rafael Alioska Kaliks
No Relationships to Disclose
 
Debora De Melo Gagliato
Honoraria - AstraZeneca; Daiichi Sankyo/Lilly; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - Daiichi Sankyo/Lilly; Lilly; Pfizer; Roche/Genentech; Teva
Research Funding - Novartis
Travel, Accommodations, Expenses - AstraZeneca; Libbs; Roche; Roche; Roche
 
ROMUALDO BARROSO-SOUSA
Consulting or Advisory Role - AstraZeneca; AstraZeneca/Daiichi Sankyo; AstraZeneca/Merck; Libbs; Lilly; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca/Daiichi Sankyo; Libbs; Lilly; MSD; Novartis; Pfizer; Roche
Research Funding - AstraZeneca/Daiichi Sankyo; Roche
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo; AstraZeneca/Daiichi Sankyo; Gilead Sciences; MSD
 
Tatiana Strava Correa
Honoraria - Daiichi Sankyo/Astra Zeneca; Novartis; Pfizer; Roche
Consulting or Advisory Role - Novartis
Research Funding - BMS Brazil; Lilly
Travel, Accommodations, Expenses - Pfizer
 
Andrea Shimada
No Relationships to Disclose
 
Daniel Negrini Batista
No Relationships to Disclose
 
Daniel Musse Gomes
No Relationships to Disclose
 
Marcelle Goldner Cesca
No Relationships to Disclose
 
Debora Souza Gaudencio
Employment - Clion- Grupo Oncoclinicas
Honoraria - Clion - Grupo Oncoclinicas
Speakers' Bureau - Instituto Oncoclinicas
Travel, Accommodations, Expenses - Novartis
 
Julio Antônio Pereira de Araujo
No Relationships to Disclose
 
Renata Colombo Bonadio
Consulting or Advisory Role - MSD
Speakers' Bureau - Adium Pharma; AstraZeneca; BMS Brazil; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; MSD; Nestle health science; Pfizer
Research Funding - AstraZeneca (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; MSD; MSD
 
Max S. Mano
Employment - Grupo Oncoclinicas
Stock and Other Ownership Interests - Fleury Group; Grupo Oncolínicas; Hypera Pharma
Honoraria - Daiichi Sankyo; DASA; Gilead Sciences; Grupo Fleury; Libbs; Lilly/ImClone; MSD Oncology; Novartis; Oncologia Brasil; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly/ImClone; MSD; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Daiichi Sankyo; Roche
(OPTIONAL) Uncompensated Relationships - Roche